AbCellera Biologics Inc.
Pharmaceutical company · Vancouver, British Columbia, Canada · Nasdaq: ABCL
AbCellera Biologics Inc. is a pharmaceutical company headquartered in Vancouver, British Columbia, Canada. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker ABCL. It has reported private securities offerings to the US SEC, most recently $75 million sold in a notice filed in 2020.
AbCellera Biologics at a glance
What does AbCellera Biologics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $74.5 million sold (2020).
Frequently asked questions about AbCellera Biologics
Where is AbCellera Biologics headquartered?
AbCellera Biologics Inc. is headquartered in Vancouver, British Columbia, Canada.
What does AbCellera Biologics do?
AbCellera Biologics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is AbCellera Biologics a public company?
Yes. AbCellera Biologics Inc. trades on Nasdaq under the ticker ABCL.
When was AbCellera Biologics founded?
The earliest incorporation on record for AbCellera Biologics Inc. is in 2012, according to public company registers.
Similar companies
- Eupraxia Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- InMed Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Clearmind Medicine Inc.Vancouver, British Columbia, Canada
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Lexaria Bioscience Corp.Kelowna, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.